Medicine and Dentistry
Wart Virus
100%
Human Papillomavirus Type 16
52%
Prevalence
23%
Wart Virus Vaccine
23%
Papillomavirus Infection
22%
Cross Protection
20%
Cervical Cancer
19%
Health Care Cost
17%
Cervical Cancer Screening
14%
Herd
14%
Cervical Screening
13%
Lifespan
11%
Genital Wart
11%
Cervical Cancer Prevention
10%
Carcinogenesis
10%
Keyphrases
High-risk Human Papillomavirus (HR-HPV)
35%
Vaccination
32%
Human Papillomavirus Vaccine
28%
HPV16
26%
Vaccine Effectiveness
14%
Papillomavirus Infections
12%
Cervical Cancer
10%
HPV Vaccine
10%
Economic Effect
10%
Health Effects
10%
Vaccination Program
10%
Herd Effect
9%
Immunization
8%
Bivalent Vaccine
8%
Incremental Cost-effectiveness Ratio
7%
Immunology and Microbiology
Wart Virus
47%
Human Papillomavirus Type 16
19%
Intestine Flora
16%
Prevalence
15%
Human Immunodeficiency Virus 1
12%
Dynamics
12%
Feces microflora
12%
Cross Protection
10%
Infectious Agent
10%
Microflora
8%
Human Microbiome
6%
Ulcerative Colitis
6%
Coinfection
6%
Human Papillomavirus Type 18
6%
Seroprevalence
6%